HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Volume 20, No. 8, August 2016 – Novel Technologies for Antibody Drug Discovery in Japan       » Global Experts Convene to Discuss China's Plan for Diabetes Prevention and Rehabilitation in 2016       » Butterflies Offer Climate Scientists Ecological Insights       » Thermal Stability of Camelid Single Domain VHH Antibody       » That Gut Feeling: How A Healthy Digestive System Has Everything To Do With It       » World Heart Day - At the Heart of Health      
BIOBOARD - MALAYSIA
Indigenous people 'at graver risk' of neglected diseases
Mass drug administration against neglected tropical diseases (NTDs) must be prioritized for indigenous communities such as the Orang Asli in Malaysia who are at graver risk of such diseases due to malnutrition and abject poverty.

This is a key recommendation of a study on indigenous or aboriginal populations published earlier this year by Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine, Texas, United States.

"Although aboriginal people make up a small percentage of the world's population, they are disproportionately affected by poverty and neglected tropical diseases," says Hotez. "Unless we act now, they could represent the groups last to benefit from potential NTD elimination endgames."

The term Orang Asli applies to more than a dozen indigenous groups comprising around 150,000 people living in peninsular Malaysia. Although Malaysia has experienced rapid economic growth since the 1970s and reduced the level of national poverty, Orang Asli communities are still classified as extremely poor. Most live in rural areas with limited basic healthcare and economic opportunities.

Several efforts have been carried out by the government and NGOs, such as the 450-bed Orang Asli hospital built on the outskirts of Kuala Lumpur, but a high prevalence of hookworm and intestinal parasitic infections, malaria, dengue and tuberculosis persists among these groups. The Orang Asli account for 50 per cent or 450-600 cases of reported malaria infections per year in peninsular Malaysia. Tuberculosis cases are 5.5 times higher than the national average rate, according to Alberto Gomes, anthropology professor at La Trobe University in Australia.

Hotez recommends that essential medicines such as ivermectin, azithromycin and deworming treatments be included in mass drug administration to control NTDs. But he notes: "Such measures are a key component of more broad and encompassing measures that include sanitation, access to clean water, good food, integrated vector control and management, childhood immunisations and personal and family hygiene."

Gomes agrees that the overall social condition of the Orang Asli must likewise be addressed as language barriers and discrimination discourage many of them from seeking medical aid.

"Generally, Orang Asli are unwilling to seek medical treatment from the government because they are often discriminated against by the mostly non-Orang Asli medical staff," Gomes says. "Orang Asli have told me that they are often treated in a condescending manner at government clinics. They claim to have been ridiculed, laughed at and scolded by medical staff. Orang Asli reticence in their communication with medical practitioners has, on occasions, led to misdiagnosis."

Source: Business Wire

Click here for the complete issue.

NEWS CRUNCH  
news CPhI's Pre-Connect Congress outlines current trends in pharma
news World Population Day 2016
news NUS Student Clinches Top Prize at National Smart Mapping Competition with Cutting-Edge Food Security Solution
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2016
January:
Guest Editorial - Biotechnology In Korea
February:
Guest Editorial - Biomedical Research Governance
March:
Guest Editorial - Life-Saving Opportunities: A Guide to Regenerative Medicine
April:
Leading-Edge ONCOLOGY
May:
Healthcare Systems & Policies in Asia
June:
Medical Devices & Healthcare Technology
July:
Water Technology and Management
August:
Novel Technologies for Antibody Drug Discovery in Japan
September:
Infectious Diseases
October:
Medical Tourism
November:
Big Data in Healthcare
December:
Evidence-based TCM
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com or Mr Edward
Copyright© 2016 World Scientific Publishing Co Pte Ltd  •  Privacy Policy